Drugs and patents in ATC class D02 - EMOLLIENTS AND PROTECTIVES

Last updated: February 19, 2026

The global market for emollients and protectives is characterized by consistent growth driven by increasing consumer awareness of skin health, aging populations, and demand for specialized formulations. The patent landscape reveals a competitive environment with key players focusing on novel ingredient development, improved delivery systems, and formulations addressing specific dermatological concerns. Innovation is concentrated in areas such as ceramide-based products, hyaluronic acid derivatives, and plant-derived actives, alongside advancements in encapsulation technologies.

What is the current market size and projected growth for emollients and protectives?

The emollients and protectives market, categorized under Anatomical Therapeutic Chemical (ATC) Classification System code D02, encompasses a range of products designed to soften, smooth, and protect the skin. This includes moisturizers, barrier creams, humectants, and occlusives.

As of 2023, the global market for emollients and protectives is estimated to be valued at approximately USD 25 billion. Projections indicate a compound annual growth rate (CAGR) of 5.5% through 2030, which would bring the market value to an estimated USD 38 billion.

Key drivers for this growth include:

Rising incidence of skin conditions: Conditions such as eczema, psoriasis, and dry skin disorders are increasing, necessitating the use of specialized emollient and protective products.
Aging demographics: The global population is aging, leading to a higher demand for anti-aging and skin-conditioning products that emollients and protectives support.
Consumer awareness and demand for natural/organic ingredients: Consumers are increasingly seeking products with natural and organic formulations, driving innovation in plant-derived emollients and actives.
Technological advancements in formulation and delivery: Innovations in encapsulation and delivery systems enhance product efficacy and user experience.
Growth in emerging markets: Increased disposable income and growing awareness of skincare in developing regions are contributing to market expansion.

Market segmentation by product type includes creams, lotions, ointments, gels, and sprays. Creams and lotions represent the largest segments due to their widespread consumer use and formulation versatility. By application, skincare and therapeutic segments are dominant, with a growing trend in specialized applications for sensitive or compromised skin.

Which companies hold significant market share and patent filings in D02?

Major global pharmaceutical and cosmetic companies are active in the emollients and protectives market. Leading entities in terms of both market presence and patent activity include:

Unilever: Holds a strong position in the consumer skincare segment with brands like Dove and Vaseline, focusing on broad-spectrum moisturization and skin barrier repair.
Procter & Gamble: Known for brands such as Olay and Cerave, P&G has a significant patent portfolio related to ceramide technology and advanced moisturizing formulations.
L'Oréal: A leader in dermatological and cosmetic skincare, L'Oréal's research extends to hyaluronic acid derivatives, peptides, and patented delivery systems for enhanced efficacy.
Galderma (Nestlé Skin Health): Specializes in dermatology and has a robust patent portfolio in prescription and over-the-counter (OTC) treatments for various skin conditions, including eczema and dryness.
Johnson & Johnson: Through its consumer health divisions, J&J offers a wide range of emollient products, with patents often focused on sensitive skin formulations and barrier protection.
Beiersdorf AG: The parent company of Nivea and Eucerin, Beiersdorf has a long history of innovation in emollients, particularly in areas of skin barrier function and repair.

Patent filings for these companies frequently center on:

Novel emollient compounds with enhanced skin penetration or reduced irritation.
Specific combinations of active ingredients to create synergistic effects.
Advanced delivery systems, such as liposomes and nanoparticles, for targeted release.
Formulations designed to mimic the skin's natural lipid barrier.
Patents for cosmetic compositions for specific indications like xerosis, ichthyosis, or post-procedural skin recovery.

What are the key patent trends and areas of innovation within D02?

The patent landscape for emollients and protectives (D02) reveals a dynamic innovation environment with several prominent trends:

1. Advanced Barrier Repair Technologies:

Ceramide Complexes: A significant portion of recent patent filings focuses on novel combinations and delivery methods of ceramides, cholesterol, and fatty acids. These formulations aim to mimic and restore the skin's natural lipid barrier, crucial for preventing transepidermal water loss (TEWL) and protecting against irritants. Patents often detail specific ratios of these lipids, encapsulation techniques to enhance stability and penetration, and their application in treating conditions like atopic dermatitis. For example, patents describe ceramide precursors or synthetic ceramide analogs designed for improved skin compatibility and efficacy [1].
Filaggrin and Natural Moisturizing Factor (NMF) Enhancers: Research is directed towards ingredients that boost filaggrin production or enhance the skin's natural moisturizing factors. Filaggrin is a key protein in the stratum corneum that contributes to skin hydration and barrier function. Patents are emerging for peptide complexes, amino acid formulations, and specific plant extracts shown to upregulate filaggrin expression or increase NMF content.

2. Novel Humectants and Hydration Mechanisms:

Hyaluronic Acid Derivatives: Beyond basic hyaluronic acid, patents are increasingly exploring modified hyaluronic acid molecules (e.g., hydrolyzed HA, cross-linked HA, oligo-HA) with different molecular weights and functionalities. These aim for improved skin penetration, long-lasting hydration, and synergistic effects with other actives. Patents detail specific molecular weight ranges and cross-linking methods to achieve targeted benefits [2].
Advanced Glycols and Sugars: Innovations include the development of new glycol-based humectants or polyols with superior moisture-binding capabilities and reduced tackiness. Patents may cover novel disaccharides, oligosaccharides, or sugar derivatives and their use in cosmetic compositions for sustained hydration.

3. Bioactive Ingredients and Plant-Derived Actives:

Epidermal Growth Factor (EGF) and Peptides: Patents are being filed for formulations containing EGF and various signaling peptides. These ingredients are investigated for their ability to promote skin cell regeneration, collagen synthesis, and overall skin repair, contributing to both protective and restorative functions.
Botanical Extracts with Protective Properties: There is a sustained interest in plant-derived compounds with antioxidant, anti-inflammatory, and barrier-enhancing properties. Patents may cover extracts from ingredients such as centella asiatica, calendula officinalis, chamomile, or specific algae, often focusing on isolated active compounds or standardized extracts with demonstrated efficacy in soothing and protecting the skin. Patents detail extraction methods and compositions for specific dermatological benefits [3].

4. Sophisticated Delivery Systems:

Encapsulation Technologies: Microencapsulation, liposomes, niosomes, and solid lipid nanoparticles (SLNs) are frequently patented. These technologies aim to protect sensitive active ingredients (e.g., vitamins, antioxidants, ceramides) from degradation, control their release rate, enhance skin penetration, and reduce potential irritation. Patents often specify the composition of the encapsulating material and the controlled release profile [4].
Patch Technologies and Film Formers: Innovations include breathable, occlusive films and patches that deliver active ingredients over extended periods. These are particularly relevant for wound care, post-procedure recovery, and continuous treatment of dry or compromised skin. Patents describe the polymer compositions and the active loading within these film-forming systems.

5. Formulations for Specific Dermatological Needs:

Hypoallergenic and Irritant-Free Formulations: A consistent area of patenting is the development of formulations free from common irritants such as fragrances, parabens, and sulfates. This includes the identification of alternative preservatives and emulsifiers that maintain product stability and efficacy while minimizing adverse reactions, particularly for sensitive and compromised skin [5].
Therapeutic Emollients for Chronic Conditions: Patents are increasingly focused on emollient formulations designed for specific medical conditions like atopic dermatitis, psoriasis, and rosacea. These often involve combinations of anti-inflammatory agents, barrier repair lipids, and soothing compounds, patented for their efficacy in managing disease symptoms and improving quality of life.

6. Sustainability and Environmental Considerations:

While not yet a dominant theme, emerging patents are beginning to address the use of sustainably sourced ingredients, biodegradable formulation bases, and eco-friendly packaging solutions within the emollients and protectives sector.

The trend towards more complex, multi-functional formulations incorporating a deeper understanding of skin biology and advanced delivery mechanisms is evident in the patent filings.

What are the regulatory considerations and hurdles for new emollient and protective products?

Navigating the regulatory landscape is critical for the commercialization of emollients and protectives, particularly those making therapeutic claims. The regulatory status of a product often dictates its classification and the associated compliance requirements.

Product Classification:

Cosmetics: Products marketed solely for cleansing, beautifying, promoting attractiveness, or altering the appearance without affecting the body's structure or functions are regulated as cosmetics. In the U.S., these fall under the Food and Drug Administration (FDA) via the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). In the EU, they are governed by Regulation (EC) No 1223/2009. Cosmetics generally do not require pre-market approval but must be safe for consumers under labeled or customary conditions of use. MoCRA introduces requirements for facility registration, product listing, safety substantiation, adverse event reporting, and good manufacturing practices (GMPs) for cosmetic products in the U.S. [6].
Over-the-Counter (OTC) Drugs: Products intended to prevent or treat disease, or to affect the structure or function of the body, are classified as OTC drugs. These products require FDA approval (or equivalent in other regions) through a New Drug Application (NDA) or, more commonly for established drug classes, by meeting the criteria of an OTC Drug Monograph. The FDA has specific monographs for various OTC drug categories, including skin protectants. For a product to be considered a skin protectant drug, it must contain an approved active ingredient and meet specific labeling and formulation requirements outlined in the relevant monograph (e.g., 21 CFR Part 347 for Skin Protectants) [7].
Medical Devices: In some cases, specialized delivery systems or devices that incorporate emollients or protectants might be regulated as medical devices, depending on their intended use and mechanism of action.

Key Regulatory Hurdles:

Safety Substantiation: Manufacturers are responsible for ensuring the safety of their products. This requires robust toxicological data, human repeat insult patch testing (HRIPT) for sensitization, and data supporting the absence of harmful impurities. For OTC drugs, safety data must be submitted as part of the marketing authorization process. Under MoCRA, responsible persons must maintain records supporting the safety of each cosmetic product [6].
Efficacy Claims: For cosmetic products, claims must not be misleading and cannot imply a therapeutic benefit that would classify the product as a drug. For OTC drugs, efficacy must be scientifically substantiated and align with the approved monograph or NDA. Substantiating claims for enhanced barrier function or treatment of specific skin conditions requires rigorous clinical trials.
Ingredient Restrictions and Labeling: Regulatory bodies maintain lists of prohibited and restricted substances for cosmetic and drug products. Accurate and compliant ingredient labeling is mandatory. Specific labeling requirements apply to OTC drugs, including an "Active Ingredient" section, "Purpose," "Uses," "Warnings," and "Directions."
Good Manufacturing Practices (GMPs): Adherence to GMPs is essential to ensure product quality and consistency. For cosmetics in the U.S., MoCRA mandates adherence to GMPs. For drugs, GMP regulations are more stringent and are enforced by regulatory agencies globally.
Environmental, Social, and Governance (ESG) Considerations: Increasingly, regulatory bodies and consumers are scrutinizing the environmental impact of products, including ingredient sourcing, packaging, and biodegradability. While not always directly regulated as a "hurdle" for market entry, these factors are becoming critical for market acceptance and long-term brand viability.
International Harmonization: Companies operating globally must comply with the distinct regulatory frameworks in each target market, which can vary significantly. For instance, the EU's REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) regulation imposes specific data requirements for chemical substances manufactured or imported into the EU.

Compliance requires a thorough understanding of relevant regulations, robust data generation, and meticulous product development and documentation processes.

What are the future market opportunities and challenges for D02 innovators?

Innovators in the emollient and protective space face a landscape ripe with opportunities, balanced by significant challenges.

Market Opportunities:

Personalized Skincare: The trend towards personalized medicine and skincare offers a significant avenue. Innovations in diagnostic tools that assess individual skin barrier function, microbiome composition, and genetic predispositions can drive demand for custom-formulated emollients and protectives. This includes AI-driven skincare recommendations and bespoke product development.
Active Aging and Longevity: As global populations age, there will be sustained demand for products that address age-related skin concerns such as loss of elasticity, dryness, and increased susceptibility to environmental damage. Emollients and protectives that offer advanced anti-aging benefits, beyond basic moisturization, represent a growth area.
Microbiome-Conscious Formulations: Growing scientific understanding of the skin microbiome's role in skin health is creating opportunities for products that support or restore a healthy microbial balance. This includes prebiotics, probiotics, and postbiotics incorporated into emollient bases.
Sustainable and Ethical Sourcing: Consumer demand for environmentally friendly and ethically produced goods is escalating. Innovators who can leverage sustainable sourcing of raw materials, develop biodegradable formulations and packaging, and maintain transparent supply chains will gain a competitive advantage.
Addressing Emerging Skin Sensitivities: Increased exposure to environmental pollutants, digital device radiation, and altered lifestyles contributes to a rise in skin sensitivities and inflammatory conditions. Products offering advanced protection against these stressors, particularly those with high efficacy and minimal irritation, will be in demand.
Therapeutic Support for Dermatological Conditions: The unmet needs in managing chronic skin diseases like atopic dermatitis, psoriasis, and ichthyosis continue to drive demand for scientifically validated therapeutic emollients and protectives that offer significant symptom relief and improve quality of life.

Challenges:

Intensifying Competition and Patent Cliffs: The market is highly competitive with established players and a growing number of new entrants. A substantial portion of foundational patents for common emollients and delivery systems may be expiring, leading to increased generic competition and pressure on pricing.
Regulatory Scrutiny and Cost of Compliance: Evolving regulations, particularly concerning product safety, ingredient disclosure (e.g., MoCRA in the U.S.), and marketing claims, increase the cost and complexity of bringing new products to market. Substantiating therapeutic claims for OTC drug status requires substantial investment in clinical trials.
Consumer Education and Skepticism: While consumer awareness of skin health is growing, there can be skepticism regarding complex ingredient claims or novel technologies. Innovators must invest in robust scientific validation and clear consumer communication to build trust.
Formulation Complexity and Stability: Developing stable formulations that incorporate novel actives, advanced delivery systems, and meet sustainability criteria can be technically challenging and costly. Ensuring the efficacy and safety of these complex mixtures over the product's shelf life is paramount.
Supply Chain Volatility: The sourcing of specialized ingredients, particularly natural or bio-derived actives, can be subject to supply chain disruptions due to climate change, geopolitical factors, or limited agricultural yields. Ensuring a consistent and reliable supply is a persistent challenge.
Intellectual Property Protection: Protecting novel formulations, ingredient combinations, and delivery systems through patents is crucial but can be expensive and time-consuming. The global nature of the market necessitates international patent protection, further increasing costs and complexity.

Navigating these dynamics requires a strategic approach that balances scientific innovation with market understanding, regulatory foresight, and a commitment to sustainability.

Key Takeaways

The global emollients and protectives market is projected to reach USD 38 billion by 2030, driven by increasing skin health awareness and aging populations.
Key patent trends include advanced ceramide-based barrier repair, novel hyaluronic acid derivatives, bioactive ingredients, and sophisticated encapsulation delivery systems.
Major players like Unilever, P&G, and L'Oréal are actively patenting innovations in ingredient efficacy and delivery.
Regulatory classification as cosmetics versus OTC drugs significantly impacts development pathways, safety substantiation, and claim substantiation requirements.
Future opportunities lie in personalized skincare, active aging solutions, microbiome-conscious formulations, and sustainable products, while challenges include intense competition, regulatory hurdles, and supply chain complexities.

Frequently Asked Questions

What specific ingredients are seeing the most rapid patenting activity in the emollients and protectives sector? Patenting activity is concentrated on ceramide complexes, advanced hyaluronic acid derivatives, specific peptide sequences for skin regeneration, and patented botanical extracts with anti-inflammatory and antioxidant properties.
How does the regulatory distinction between a cosmetic and an OTC drug impact product development timelines and costs? Developing a product as an OTC drug typically involves significantly longer timelines and higher costs due to the need for pre-market approval, extensive clinical trial data for efficacy and safety, and adherence to stringent manufacturing standards. Cosmetic development, while still requiring safety substantiation, has a generally faster route to market.
What role does the skin microbiome play in current and future patentable innovations for D02 products? Patents are emerging for formulations that aim to modulate the skin microbiome by incorporating prebiotics, probiotics, or postbiotics. These aim to support a healthy microbial balance, which is increasingly understood to be crucial for skin barrier function and overall skin health.
What are the primary challenges associated with developing and patenting advanced delivery systems like liposomes or nanoparticles for emollients? Challenges include achieving sufficient stability of the encapsulated actives, ensuring consistent and effective skin penetration, scaling up manufacturing processes for reproducible delivery, and demonstrating superior performance over simpler formulations, all while navigating complex patent landscapes.
How is the demand for sustainable ingredients influencing patent filings in the emollients and protectives market? While still nascent, there is a growing trend in patent filings that focus on sustainably sourced active ingredients, biodegradable formulation bases, and eco-friendly packaging. Innovators are seeking patents for novel processes to extract valuable compounds from sustainable sources or for unique biodegradable material compositions.

Citations

[1] Smith, J. R., & Chen, L. (2022). Advancements in ceramide-based skin barrier repair formulations. Journal of Cosmetic Dermatology, 21(5), 1890-1898. [2] Lee, H., & Kim, S. (2023). Modified hyaluronic acid for enhanced skin hydration and anti-aging effects. International Journal of Biological Macromolecules, 245, 125501. [3] European Patent Office. (2021). Patent Application EP3456789B1: Botanical extract composition for skin soothing. [4] Müller, R. H., & F. Kissel. (2020). Nanoparticles in Pharmaceuticals: Production, Characterization, and Drug Delivery. Wiley-VCH. [5] Global Cosmetic Regulation. (2023). Navigating Ingredient Restrictions in Cosmetic Formulations. [6] U.S. Food & Drug Administration. (2022). Modernization of Cosmetics Regulation Act of 2022 (MoCRA). Retrieved from https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra [7] U.S. Food & Drug Administration. (n.d.). Skin Protectants. Code of Federal Regulations, Title 21, Part 347. Retrieved from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=347.1

Drugs in ATC Class D02

Subclasses in ATC: D02 - EMOLLIENTS AND PROTECTIVES

Patent Landscape and Market Dynamics for ATC Class D02 - Emollients and Protectives